Marker Therapeutics Inc. (MRKR) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Marker Therapeutics Inc.

    NASDAQ: MRKR · Real-Time Price · USD
    0.95
    0.04 (4.40%)
    At close: Oct 03, 2025, 3:59 PM
    0.96
    0.40%
    After-hours: Oct 03, 2025, 07:38 PM EDT

    Marker Therapeutics Ratios and Metrics

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    PE Ratio
    		 -2.6 -5.88 -0.74 -1.74
    PEG Ratio
    		 0.07 0.13 0.02 0.17
    PS Ratio
    		 4.24 14.63 2.47 58.53
    PB Ratio
    		 1.50 3.45 1.13 1.65
    P/FCF Ratio
    		 -2.56 -2.95 -0.7 -2.39
    P/OCF Ratio
    		 -2.56 -2.95 -0.82 -2.66
    OCF/S Ratio
    		 -1.66 -4.97 -3 -21.96
    Debt / Equity Ratio
    		 n/a n/a 0.39 0.27
    Quick Ratio
    		 6.36 5.89 2.14 3.56
    Current Ratio
    		 6.36 5.57 2.14 3.56
    Asset Turnover
    		 0.30 0.19 0.26 0.02
    Interest Coverage
    		 n/a n/a n/a n/a
    Return on Equity
    		 -0.58 -0.59 -1.53 -0.95
    Return on Assets
    		 -0.49 -0.48 -0.87 -0.61
    Return on Invested Capital
    		 -0.6 -1.04 -0.73 -0.7
    Dividend Yield
    		 n/a n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a n/a
    Gross Profit Margin
    		 -1.04 -2.15 0.59 -1.55
    Net Profit Margin
    		 -1.63 -2.49 -3.32 -33.72
    Pretax Profit Margin
    		 -1.62 -4.24 -2.2 -33.72
    Operating Profit Margin
    		 -1.69 -4.4 -2.2 -31.79
    FCF Margin
    		 -1.66 -4.97 -3.54 -24.49
    EBITDA Margin
    		 -0.69 -3.4 -2.2 -29.24

    Add to Watchlist